<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Open Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Open Biol</journal-id>
<journal-id journal-id-type="publisher-id">RSOB</journal-id>
<journal-id journal-id-type="hwp">royopenbio</journal-id>
<journal-title-group>
<journal-title>Open Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-2441</issn>
<publisher>
<publisher-name>The Royal Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31795919</article-id>
<article-id pub-id-type="pmc">6936252</article-id>
<article-id pub-id-type="doi">10.1098/rsob.190222</article-id>
<article-id pub-id-type="publisher-id">rsob190222</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>1001</subject>
<subject>33</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
<subj-group subj-group-type="leader">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Loss of TOP3B leads to increased R-loop formation and genome instability</article-title>
<alt-title alt-title-type="short">TOP3B, R-loop and genomic instability</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wallis</surname>
<given-names>Mathew</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petrovic</surname>
<given-names>Vida</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Challis</surname>
<given-names>Jackie</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-5569-0609</contrib-id>
<name>
<surname>Kalitsis</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-7835-3020</contrib-id>
<name>
<surname>Hudson</surname>
<given-names>Damien F.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="corresp" rid="cor2"></xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>Murdoch Children's Research Institute, Royal Children's Hospital</institution>, <addr-line>Melbourne, Victoria 3052</addr-line>, <country>Australia</country></aff>
<aff id="af2"><label>2</label><institution>Department of Paediatrics, University of Melbourne, Royal Children's Hospital</institution>, <addr-line>Melbourne, Victoria 3052</addr-line>, <country>Australia</country></aff>
<aff id="af3"><label>3</label><institution>Tasmanian Clinical Genetics Services, Royal Hobart Hospital</institution>, <addr-line>Hobart, Tasmania 7001</addr-line>, <country>Australia</country></aff>
<aff id="af4"><label>4</label><institution>School of Medicine and Menzies Institute for Medical Research, University of Tasmania</institution>, <addr-line>Hobart, Tasmania 7001</addr-line>, <country>Australia</country></aff>
<aff id="af5"><label>5</label><institution>Cytogenetics Department, Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital</institution>, <addr-line>Parkville, Victoria 3052</addr-line>, <country>Australia</country></aff>
<author-notes>
<corresp id="cor1">e-mail: <email>paul.kalitsis@mcri.edu.au</email></corresp>
<corresp id="cor2">e-mail: <email>damien.hudson@mcri.edu.au</email></corresp>
<fn fn-type="other">
<p>Electronic supplementary material is available online at <uri xlink:href="https://doi.org/10.6084/m9.figshare.c.4740857">https://doi.org/10.6084/m9.figshare.c.4740857</uri>.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>4</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>4</day>
<month>12</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>9</volume>
<issue>12</issue>
<elocation-id>190222</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="rsob-9-190222.pdf"></self-uri>
<self-uri xlink:href="rsob190222.thumb.gif" xlink:role="icon"></self-uri>
<self-uri content-type="reviewer_comments" xlink:href="rsob190222_review_history.pdf"></self-uri>
<abstract>
<p>Topoisomerase III beta (TOP3B) is one of the least understood members of the topoisomerase family of proteins and remains enigmatic. Our recent data shed light on the function and relevance of TOP3B to disease. A homozygous deletion for the TOP3B gene was identified in a patient with bilateral renal cancer. Analyses in both patient and modelled human cells show the disruption of TOP3B causes genome instability with a rise in DNA damage and chromosome bridging (mis-segregation). The primary molecular defect underlying this pathology is a significant increase in R-loop formation. Our data show that TOP3B is necessary to prevent the accumulation of excessive R-loops and identify TOP3B as a putative cancer gene, and support recent data showing that R-loops are involved in cancer aetiology.</p>
</abstract>
<kwd-group>
<kwd>topoisomerase</kwd>
<kwd>TOP3B</kwd>
<kwd>R-loop</kwd>
<kwd>genomic instability</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Health and Medical Research Council</institution>
<institution-id>http://dx.doi.org/10.13039/501100000925</institution-id>
</institution-wrap>
</funding-source>
<award-id>GNT1127209</award-id>
<award-id>GNT1145188</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>December 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1.</label>
<title>Introduction</title>
<p>Topoisomerase III beta (TOP3B) is a member of the IA subfamily of topoisomerases, which unwind negatively supercoiled DNA by cutting a single strand of DNA and passing it through a second single DNA strand [<xref ref-type="bibr" rid="RSOB190222C1">1</xref>]. Two TOP3 enzymes exist in higher eukaryotes that have diverged from a single ancestor present in unicellular organisms [<xref ref-type="bibr" rid="RSOB190222C2">2</xref>]. TOP3A and TOP3B both unwind negatively supercoiled DNA, but their molecular and <italic>in vivo</italic> functions differ [<xref ref-type="bibr" rid="RSOB190222C3">3</xref>]. TOP3A is essential in all species and associates with BLM, RMI1 and RMI2 to form the BTRR complex, which dissolves Holliday junctions that arise during homologous recombination [<xref ref-type="bibr" rid="RSOB190222C4">4</xref>]. Unlike TOP3A [<xref ref-type="bibr" rid="RSOB190222C5">5</xref>], <italic>Top3b</italic> null mice are viable but present with tissue lesions and a reduced lifespan [<xref ref-type="bibr" rid="RSOB190222C6">6</xref>], as well as chromosome instability in spermatocytes and infertility, which becomes more pronounced after successive homozygous breeding [<xref ref-type="bibr" rid="RSOB190222C7">7</xref>].</p>
<p>TOP3A and TOP3B have developed distinct specificities for DNA loop (D-loop) and RNA loop (R-loop) structures [<xref ref-type="bibr" rid="RSOB190222C8">8</xref>], respectively. In humans, TOP3B possesses dual activities for processing topological problems for both DNA and RNA, whereas TOP3A is DNA specific [<xref ref-type="bibr" rid="RSOB190222C9">9</xref>]. D-loops and R-loops are bubble-like structures where one of the strands of DNA (or RNA) is displaced by a homologous strand of DNA (D-loop) or RNA (R-loop) [<xref ref-type="bibr" rid="RSOB190222C10">10</xref>,<xref ref-type="bibr" rid="RSOB190222C11">11</xref>]. D-loops commonly appear during gene transcription and downstream processing of RNA, DNA repair, DNA replication and meiotic recombination [<xref ref-type="bibr" rid="RSOB190222C12">12</xref>]. R-loops are DNA–RNA hybrids that form when nascent RNA hybridizes with the DNA template, leaving the non-template DNA single stranded [<xref ref-type="bibr" rid="RSOB190222C13">13</xref>,<xref ref-type="bibr" rid="RSOB190222C14">14</xref>]. R-loop formation is highly dependent upon three factors: DNA nicks, high G density and negative supercoiling [<xref ref-type="bibr" rid="RSOB190222C15">15</xref>,<xref ref-type="bibr" rid="RSOB190222C16">16</xref>]. They most commonly occur when a newly transcribed G-rich RNA anneals back to the C-rich template DNA strand, largely displacing the other DNA strand [<xref ref-type="bibr" rid="RSOB190222C17">17</xref>].</p>
<p>It would seem that R-loops would be deleterious to the cell. However, recent data show that R-loops at the 5′ end of genes can protect against DNA methylation, help initiate class switch recombination at the immunoglobulin H (IgH) locus by causing double-stranded breaks in DNA and aid transcription termination at the 3′ end of genes [<xref ref-type="bibr" rid="RSOB190222C17">17</xref>–<xref ref-type="bibr" rid="RSOB190222C19">19</xref>]. Despite the positive role R-loops play in the cell cycle, excessive R-loop formation can lead to genome instability [<xref ref-type="bibr" rid="RSOB190222C16">16</xref>,<xref ref-type="bibr" rid="RSOB190222C20">20</xref>].</p>
<p>Several studies implicate TOP3B in processing R-loops. TOP3B binds in a complex with TDRD3, and <italic>Tdrd3</italic> null mice accumulate R-loops at the C-MYC locus [<xref ref-type="bibr" rid="RSOB190222C21">21</xref>]. <italic>In vitro</italic> assays in fly and human show that TOP3B activity can relax negatively supercoiled DNA [<xref ref-type="bibr" rid="RSOB190222C8">8</xref>,<xref ref-type="bibr" rid="RSOB190222C21">21</xref>], an activity that prevents the formation of R-loops.</p>
<p>TOP3B also appears to play an important role in neural cell biology. A study of an isolated northern Finnish family found that the TOP3B gene was associated with schizophrenia and cognitive impairment [<xref ref-type="bibr" rid="RSOB190222C22">22</xref>]. A TOP3B-associated complex has been identified consisting of TOP3B–TDRD3–FMRP (fragile X mental retardation protein) and has been linked to the processing and regulation of neuronal expressed genes [<xref ref-type="bibr" rid="RSOB190222C21">21</xref>–<xref ref-type="bibr" rid="RSOB190222C23">23</xref>]. The FMRP binds polyribosomal RNA and inhibits the translation of neuronal mRNAs. The TOP3B–TDRD3–FMRP complex prevents the accumulation of transcribed RNAs in cytoplasmic compartments when the cell is stressed [<xref ref-type="bibr" rid="RSOB190222C23">23</xref>]. Recent data have further reinforced the pivotal role TOP3B plays in RNA biology. Drosophila S2 cells display defective heterochromatin formation and transcriptional silencing when TOP3B is disrupted, which is reminiscent of mutants in the RNAi-induced silencing complex (RISC) [<xref ref-type="bibr" rid="RSOB190222C24">24</xref>].</p>
<p>While new data are emerging for TOP3B, there are still anomalies regarding the protein and its exact functions remain unclear. Here, we present only the second example of a patient without the TOP3B gene. Our new data, using lymphoblasts from a bilateral renal cancer patient deleted for TOP3B, show multiple hallmarks of genome instability that were pheno-copied in modelled TOP3B null cells of a different lineage. We show TOP3B loss results in excessive R-loop formation, DNA damage and chromosomal instability, and predisposes cells to cancer. Our data also support the growing connection between R-loops and cancer [<xref ref-type="bibr" rid="RSOB190222C11">11</xref>,<xref ref-type="bibr" rid="RSOB190222C16">16</xref>].</p>
</sec>
<sec id="s2">
<label>2.</label>
<title>Results</title>
<sec id="s2a">
<label>2.1.</label>
<title>Identification of a patient with a homozygous deletion of TOP3B</title>
<p>An adult male patient was referred to Adult Cancer Genetics, Austin Hospital, Melbourne with bilateral clear cell renal cancer, diagnosed at the ages of 49 and 52 years. The patient had normal growth, and abdominal and chest CT imaging revealed no cystic lesions of liver or pancreas or lungs. On examination, he was normocephalic with a head circumference of 56.6 cm, and he was not syndromic in appearance. The patient displayed sun-damaged skin with hypopigmented macules and had a number of small (less than 5 mm) hypopigmented pitted scars on his upper chest/back. The proband and his parents did not have schizophrenia or cognitive impairment. He did not have a family history of renal cancer, and his family history was not suggestive of a known renal cancer-predisposing syndrome. However, bilateral renal cancer is rare for a person of 50 years of age, so further genetic testing was suggested [<xref ref-type="bibr" rid="RSOB190222C25">25</xref>]. Indeed, studies in Iceland found that over 60% of patients with renal cancer had a genetic predisposition [<xref ref-type="bibr" rid="RSOB190222C26">26</xref>]. The patient had normal <italic>VHL</italic> gene sequencing via the 94 gene Illumina TruSight Cancer Kit on the Illumina MiSeq system, normal sanger sequencing of the <italic>VHL</italic> promoter region, normal <italic>VHL</italic> MLPA (salsa kit P016-C2) testing and normal bioinformatic analysis of other genes known to cause an inherited susceptibility to renal cancer using Illumina TruSight data. Additional testing included normal tumour tissue SDHA/SDHB immunohistochemistry and a normal g-banded karyotype to exclude a translocation involving chromosome 3. SNP-microarray analysis was performed using the high-density Illumina Human Omni2.5 chip. A homozygous deletion was found on 22q11.22 chr22: 22 305 007–22 579 821 (human genome build GRCM37/hg19) that spanned the TOP3B gene (<xref ref-type="fig" rid="RSOB190222F1">figure 1</xref><italic>a</italic>). The deletion was approximately 275 kb and was driven by 4 kb segmental duplicated regions (99.5% homology) juxtaposed on either side of the deletion (<xref ref-type="fig" rid="RSOB190222F1">figure 1</xref><italic>a</italic>). Both parents were heterozygote for the deletion. A non-coding RNA with no known function is the only other transcript detected in the deleted area.
<fig id="RSOB190222F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Homozygous deletion spanning the TOP3B region. (<italic>a</italic>) Patient genomic DNA was hybridized onto an Infinium Omni2.5 (Illumina) microarray chip for high-resolution copy number analysis. SNP genotyping and copy number levels revealed a homozygous deletion spanning a maximum of 275 kb at chr22: 22 305 007–22 579 821 (human genome build GRCM37/hg19). Note the lack of SNP heterozygosity across the deleted region, shown by blue dots in the B-allele frequency plot. (<italic>b</italic>) (i) Immunoblots of TOP3B and loading control α-tubulin in control (C), parental heterozygote controls (F = father, M = mother) and homozygous TOP3B-deleted patient (P) lymphoblasts. (ii) Immunoblots of TOP3B and α-tubulin in three modelled HCT116 TOP3B null clones (1.12, 4.8 and 4.9), with parental HCT116 (HCT) as a control.</p></caption><graphic xlink:href="rsob-9-190222-g1"></graphic></fig></p>
<p>To determine the frequency of the TOP3B deletion between the two 4 kb segmental duplicated regions, we searched the region in the gnomAD human structural variant dataset derived from 10 738 genomes from unrelated individuals (gnomad.broadinstitute.org). The allele frequency is 9/21 470 (0.042%), with no homozygous deletions being detected. Interestingly, the allele frequency for duplications is higher at 0.27%, with one homozygous event being identified.</p>
<p>To determine whether homozygous deletions around the TOP3B gene are enriched in cancer mutation datasets, we examined the frequency in the <italic>C</italic>atalogue <italic>O</italic>f <italic>S</italic>omatic <italic>M</italic>utations <italic>I</italic>n <italic>C</italic>ancer (GRCh38 COSMIC v89, cancer.sanger.ac.uk/cosmic). We identified 19 with homozygous deletions from 11 032 samples (0.17%) (<xref ref-type="table" rid="RSOB190222TB1">table 1</xref>). TOP3B deletions were found in a broad range of cancer tissue types (<xref ref-type="table" rid="RSOB190222TB2">table 2</xref>). This deletion frequency was markedly elevated compared with the gnomAD dataset frequency of 0.042% for heterozygotes. The increase may reflect the inherent genome instability in cancer genomes, or it is possible that this homozygous variant is a driver in cancer progression. More work needs to be done to investigate this finding.
<table-wrap id="RSOB190222TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>TOP3B homozygous deletion frequency was examined in the Catalogue Of Somatic Mutations In Cancer (GRCh38 COSMIC v89, cancer.sanger.ac.uk/cosmic).</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">tissues</th><th align="left" colspan="1" rowspan="1">no. of samples</th><th align="left" colspan="1" rowspan="1">homozygous deletion</th><th align="left" colspan="1" rowspan="1">% of samples</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">adrenal gland</td><td colspan="1" rowspan="1">268</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0.746268657</td></tr><tr><td colspan="1" rowspan="1">breast</td><td colspan="1" rowspan="1">1544</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.064766839</td></tr><tr><td colspan="1" rowspan="1">central nervous system</td><td colspan="1" rowspan="1">1093</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.091491308</td></tr><tr><td colspan="1" rowspan="1">endometrium</td><td colspan="1" rowspan="1">598</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.16722408</td></tr><tr><td colspan="1" rowspan="1">haematopoietic and lymphoid</td><td colspan="1" rowspan="1">836</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">kidney</td><td colspan="1" rowspan="1">1027</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.097370983</td></tr><tr><td colspan="1" rowspan="1">large intestine</td><td colspan="1" rowspan="1">773</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.129366106</td></tr><tr><td colspan="1" rowspan="1">liver</td><td colspan="1" rowspan="1">692</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.144508671</td></tr><tr><td colspan="1" rowspan="1">lung</td><td colspan="1" rowspan="1">1185</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0.168776371</td></tr><tr><td colspan="1" rowspan="1">oesophagus</td><td colspan="1" rowspan="1">546</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.183150183</td></tr><tr><td colspan="1" rowspan="1">ovary</td><td colspan="1" rowspan="1">729</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0.411522634</td></tr><tr><td colspan="1" rowspan="1">pleura</td><td colspan="1" rowspan="1">108</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1.851851852</td></tr><tr><td colspan="1" rowspan="1">skin</td><td colspan="1" rowspan="1">650</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0.307692308</td></tr><tr><td colspan="1" rowspan="1">soft tissue</td><td colspan="1" rowspan="1">268</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">testis</td><td colspan="1" rowspan="1">152</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.657894737</td></tr><tr><td colspan="1" rowspan="1">upper aerodigestive tract</td><td colspan="1" rowspan="1">563</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">total</td><td colspan="1" rowspan="1">11 032</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0.172226251</td></tr></tbody></table></table-wrap>
<table-wrap id="RSOB190222TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>TOP3B homozygous deletions were found in a broad range of cancer tissue types.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">sample name</th><th align="left" colspan="1" rowspan="1">tissue</th><th align="left" colspan="1" rowspan="1">chr</th><th align="left" colspan="1" rowspan="1">start</th><th align="left" colspan="1" rowspan="1">end</th><th align="left" colspan="1" rowspan="1">size</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">TCGA-OR-A5J2-01</td><td colspan="1" rowspan="1">adrenal gland</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 940</td><td colspan="1" rowspan="1">22 199 941</td><td colspan="1" rowspan="1">239 001</td></tr><tr><td colspan="1" rowspan="1">TCGA-OR-A5JD-01</td><td colspan="1" rowspan="1">adrenal gland</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 940</td><td colspan="1" rowspan="1">22 219 595</td><td colspan="1" rowspan="1">258 655</td></tr><tr><td colspan="1" rowspan="1">TCGA-A2-A0SW-01</td><td colspan="1" rowspan="1">breast</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 953 147</td><td colspan="1" rowspan="1">22 326 572</td><td colspan="1" rowspan="1">373 425</td></tr><tr><td colspan="1" rowspan="1">TCGA-DB-A64 L-01</td><td colspan="1" rowspan="1">central nervous system</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 936 109</td><td colspan="1" rowspan="1">22 219 595</td><td colspan="1" rowspan="1">283 486</td></tr><tr><td colspan="1" rowspan="1">TCGA-A5-A0G1-01</td><td colspan="1" rowspan="1">endometrium</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 734</td><td colspan="1" rowspan="1">22 225 090</td><td colspan="1" rowspan="1">264 356</td></tr><tr><td colspan="1" rowspan="1">TCGA-EU-5905-01</td><td colspan="1" rowspan="1">kidney</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 953 147</td><td colspan="1" rowspan="1">22 225 090</td><td colspan="1" rowspan="1">271 943</td></tr><tr><td colspan="1" rowspan="1">TCGA-AG-A02G-01</td><td colspan="1" rowspan="1">large intestine</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 776 250</td><td colspan="1" rowspan="1">23 147 792</td><td colspan="1" rowspan="1">1 371 542</td></tr><tr><td colspan="1" rowspan="1">TCGA-G3-A25 W-01</td><td colspan="1" rowspan="1">liver</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 936 109</td><td colspan="1" rowspan="1">22 219 595</td><td colspan="1" rowspan="1">283 486</td></tr><tr><td colspan="1" rowspan="1">TCGA-56-8622-01</td><td colspan="1" rowspan="1">lung</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 717</td><td colspan="1" rowspan="1">22 225 429</td><td colspan="1" rowspan="1">264 712</td></tr><tr><td colspan="1" rowspan="1">TCGA-63-6202-01</td><td colspan="1" rowspan="1">lung</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 734</td><td colspan="1" rowspan="1">22 225 408</td><td colspan="1" rowspan="1">264 674</td></tr><tr><td colspan="1" rowspan="1">OACM5-1</td><td colspan="1" rowspan="1">oesophagus</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 833 371</td><td colspan="1" rowspan="1">23 806 086</td><td colspan="1" rowspan="1">1 972 715</td></tr><tr><td colspan="1" rowspan="1">TCGA-25-1628-01</td><td colspan="1" rowspan="1">ovary</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 785 127</td><td colspan="1" rowspan="1">22 354 061</td><td colspan="1" rowspan="1">5 68 934</td></tr><tr><td colspan="1" rowspan="1">TCGA-61-2018-01</td><td colspan="1" rowspan="1">ovary</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 926 720</td><td colspan="1" rowspan="1">22 187 441</td><td colspan="1" rowspan="1">260 721</td></tr><tr><td colspan="1" rowspan="1">TCGA-61-2109-01</td><td colspan="1" rowspan="1">ovary</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 819 244</td><td colspan="1" rowspan="1">21 967 362</td><td colspan="1" rowspan="1">148 118</td></tr><tr><td colspan="1" rowspan="1">IST-MES1</td><td colspan="1" rowspan="1">pleura</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 790 812</td><td colspan="1" rowspan="1">22 249 007</td><td colspan="1" rowspan="1">458 195</td></tr><tr><td colspan="1" rowspan="1">TCGA-ZN-A9VQ-01</td><td colspan="1" rowspan="1">pleura</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 940</td><td colspan="1" rowspan="1">22 200 684</td><td colspan="1" rowspan="1">239 744</td></tr><tr><td colspan="1" rowspan="1">TCGA-GN-A269-01</td><td colspan="1" rowspan="1">skin</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 960 940</td><td colspan="1" rowspan="1">22 225 090</td><td colspan="1" rowspan="1">264 150</td></tr><tr><td colspan="1" rowspan="1">VMRC-MELG</td><td colspan="1" rowspan="1">skin</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 917 856</td><td colspan="1" rowspan="1">23 097 569</td><td colspan="1" rowspan="1">1 179 713</td></tr><tr><td colspan="1" rowspan="1">TCGA-2G-AAKL-01</td><td colspan="1" rowspan="1">testis</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">21 953 147</td><td colspan="1" rowspan="1">22 225 408</td><td colspan="1" rowspan="1">272 261</td></tr></tbody></table></table-wrap></p>
<p>Two recent case reports, involving similar TOP3B genomic deletions associated with neurological disorders, have been reported [<xref ref-type="bibr" rid="RSOB190222C27">27</xref>,<xref ref-type="bibr" rid="RSOB190222C28">28</xref>]. Close inspection of the microarray results shows that these structural variants are heterozygous deletions and hence the significance of a single-copy loss remains less significant given the approximate allele frequency of 1/2000 in the general population and up to 1/750 within certain sub-populations. TOP3B genomic deletions are enriched in northeastern sub-isolates compared with the rest of Finland [<xref ref-type="bibr" rid="RSOB190222C22">22</xref>]; however, outside of the Finnish population, deletions involving <italic>TOP3B</italic> appear to be seen with approximately equal frequency between cases and controls [<xref ref-type="bibr" rid="RSOB190222C29">29</xref>,<xref ref-type="bibr" rid="RSOB190222C30">30</xref>].</p>
<p>Immunoblotting with an antibody against TOP3B showed no detectable protein for the homozygous patient (P). Interestingly, heterozygote parents (F and M) displayed a detectable loss of TOP3B protein compared with lymphoblast control cells (C) (<xref ref-type="fig" rid="RSOB190222F1">figure 1</xref><italic>b</italic>(i); electronic supplementary material, figure S1<italic>a</italic>). To our knowledge, this represents only the second reported case of a homozygous deletion for TOP3B and the first where cell lines have been available for analyses (we are the second laboratory to report a TOP3B null patient [<xref ref-type="bibr" rid="RSOB190222C22">22</xref>]). Sister-chromatid exchange levels were not elevated when compared with parental controls (electronic supplementary material, figure S1<italic>b</italic> left). It is of note that the patient had no history of mental illness. This is in contrast with other studies that have linked the TOP3B gene to autism and schizophrenia [<xref ref-type="bibr" rid="RSOB190222C22">22</xref>,<xref ref-type="bibr" rid="RSOB190222C23">23</xref>] and juvenile myoclonic epilepsy [<xref ref-type="bibr" rid="RSOB190222C28">28</xref>]. A semen sample was taken from the TOP3B null patient and showed a significant reduction in total sperm (400 000 sperm ml<sup>−1</sup> compared with the normal concentration greater than 15 000 000 sperm ml<sup>−1</sup>) and motility 0% (normal &gt; 50%). The fertility analysis is consistent with a TOP3B null mouse study, which showed a high incidence of aneuploidy in mouse spermatocytes [<xref ref-type="bibr" rid="RSOB190222C7">7</xref>].</p>
</sec>
<sec id="s2b">
<label>2.2.</label>
<title>Loss of TOP3B increases DNA damage and genomic instability</title>
<p>The TOP3B null patient showed no mental illness, but instead presented with bilateral clear cell renal cancer and multifocal and nodular lesions. Genome instability can lead to cancer progression. A common marker of genome instability is heightened levels of micronuclei that usually arise as a result of chromosome loss or fragmented chromosomes not being incorporated into the daughter nuclei. We determined if the loss of TOP3B increased the incidence of micronuclei compared with parental controls (<xref ref-type="fig" rid="RSOB190222F2">figure 2</xref>). Patient lymphoblast null cells, parental heterozygote lymphoblast control cells, CRISPR–Cas9 engineered HCT116 TOP3B null cells and the HCT116 isogenic control cell line were used. HCT116 TOP3B null clones were created independently (using different guide RNAs) and one null from each guide RNA was used for all subsequent cell biology analyses. HCT116 TOP3B null clones (Top3B_1.12 and Top3B_4.8) were sequenced across the TOP3B Cas9 cut site and no TOP3B protein was detected by immunoblot (<xref ref-type="fig" rid="RSOB190222F1">figure 1</xref><italic>b</italic>(ii)).
<fig id="RSOB190222F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Loss of TOP3B results in increased DNA damage. (<italic>a</italic>) Micronuclei levels were determined in (i) control (C), parental heterozygote controls (F = father, M = mother) and homozygous TOP3B-deleted patient (P) lymphoblasts and (ii) wild-type HCT116 (HCT) and TOP3B null clones (Top3B_1.12 and Top3B_4.8). Patient TOP3B null and HCT116 null clones show an increase in micronuclei relative to controls. Inserts are representative images of cells with micronuclei. Data were collected from three independent experiments, with at least 1000 cells scored for each experiment. (<italic>b</italic>) Representative images for (i) lymphoblasts and (ii) HCT116 cells stained for γ-H2AX. (<italic>c</italic>) (i) Patient lymphoblasts and (ii) HCT116 TOP3B null clones show a significant increase in γ-H2AX signal. Data were collected from three independent experiments, with at least 150 cells scored at each experiment. Asterisk denotes <italic>p</italic> &lt; 0.05. n.s., no significant difference. Scale bar, 5 µm.</p></caption><graphic xlink:href="rsob-9-190222-g2"></graphic></fig></p>
<p>Patient lymphoblast cells significantly increased micronuclei formation compared with parental controls (3.74% in P, 2.03% in M, 1.64% in F and 0.72% in C; <xref ref-type="fig" rid="RSOB190222F2">figure 2</xref><italic>a</italic>). HCT116 TOP3B null cells showed increased micronuclei formation (<xref ref-type="fig" rid="RSOB190222F2">figure 2</xref><italic>a</italic>). Overall, the data show that loss of TOP3B causes a mild increase in micronuclei formation, which is suggestive of genome instability. Consistently, null cells from both patient lymphoblast and HCT116 TOP3B<sup>−/−</sup> cells showed a significant rise in DNA damage, as assessed by immunofluorescence staining in <xref ref-type="fig" rid="RSOB190222F2">figure 2</xref><italic>b</italic>, using an antibody to γ-H2AX (phosphor S139) that binds specifically at sites of double-stranded DNA breaks [<xref ref-type="bibr" rid="RSOB190222C31">31</xref>]. γ-H2AX foci were increased two- to threefold in patient lymphoblast cells and two independent null HCT116 cells compared with controls (<xref ref-type="fig" rid="RSOB190222F2">figure 2</xref><italic>b</italic>). Terradas <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB190222C32">32</xref>] reported that a high fraction of cells with micronuclei displaying discrete γ-H2AX foci were observed at an early stage post-irradiation. We found a very large rise in the number of cells with micronuclei displaying discrete γ-H2AX foci in HCT116 null cells (electronic supplementary material, figure S1<italic>a</italic>).</p>
<p>Genome instability can arise as a result of defective chromosome segregation. We therefore tested whether null cells showed chromosome bridging defects (<xref ref-type="fig" rid="RSOB190222F3">figure 3</xref>). Bulky DNA bridges are readily visible with conventional DAPI staining while ultrafine DNA bridges (UFBs) are not visible with DNA dyes but can be detected using Plk1-interacting checkpoint helicase (PICH) as a marker [<xref ref-type="bibr" rid="RSOB190222C33">33</xref>]. Normal cells display a significant amount of UFBs during early anaphase, but these are generally resolved by the BTRR complex and the percentage of cells with UFBs drops markedly in anaphase B [<xref ref-type="bibr" rid="RSOB190222C33">33</xref>,<xref ref-type="bibr" rid="RSOB190222C34">34</xref>]. Increases in UFBs are often a result of unresolved replication intermediates that persist into mitosis, while bulky bridges are more commonly formed with problems arising such as under-condensed or entangled mitotic chromosomes during mitosis [<xref ref-type="bibr" rid="RSOB190222C34">34</xref>,<xref ref-type="bibr" rid="RSOB190222C35">35</xref>]. Our data show a significant rise in anaphase B UFBs in both null patient lymphoblast and HCT116 TOP3B null cells relative to controls (<xref ref-type="fig" rid="RSOB190222F3">figure 3</xref>). Bulky bridges were increased in TOP3B null patient versus control cells (<xref ref-type="fig" rid="RSOB190222F3">figure 3</xref><italic>a</italic>(iii)), but a statistically significant increase in bulky bridges between null cells and controls in modelled HCT116 cell lines was observed only in one clone (<xref ref-type="fig" rid="RSOB190222F3">figure 3</xref><italic>b</italic>(iii)).
<fig id="RSOB190222F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Increased DNA bridging as a result of loss of TOP3B. (<italic>a</italic>) DNA bridging was determined by staining lymphoblasts with PICH. (i) Representative images of anaphase B control (C), parental controls (F, M) and patient (P) cells stained with anti-PICH (red) and DAPI for DNA (blue). (ii) PICH bridges were quantitated. (iii) DNA bridging detectable by DAPI in patient and control cells and quantification. (<italic>b</italic>) (i) Representative images of anaphase B TOP3B null HCT116 cells (Top3B_1.12 and Top3B_4.8) stained with anti-PICH (green) and DAPI for DNA (blue). (ii) PICH bridges were quantitated. (iii) DNA bridging detectable by DAPI in control HCT116 (HCT) and HCT116 TOP3B null cells and quantification. Data are from three independent experiments, with at least 50 anaphase B cells scored at each experiment. Asterisk denotes <italic>p</italic> &lt; 0.05. n.s., no significant difference. Scale bar, 5 µm.</p></caption><graphic xlink:href="rsob-9-190222-g3"></graphic></fig></p>
</sec>
<sec id="s2c">
<label>2.3.</label>
<title>Loss of TOP3B results in increased R-loops</title>
<p>TOP3B alone has affinity for R-loops and it is also part of the TDRD3 complex, which is involved in processing R-loops. Therefore, we hypothesized that the genome instability we observed was a result of increased R-loop formation. To test this, we used a monoclonal antibody (S9.6) that specifically recognizes RNA : DNA hybrids in a sequence-independent manner [<xref ref-type="bibr" rid="RSOB190222C36">36</xref>,<xref ref-type="bibr" rid="RSOB190222C37">37</xref>] and analysed patient and HCT116 TOP3B null cells with their respective controls (<xref ref-type="fig" rid="RSOB190222F4">figure 4</xref>). The S9.6 antibody shows especially strong signals at nucleoli, which contain R-loop-prone ribosomal arrays [<xref ref-type="bibr" rid="RSOB190222C38">38</xref>]. Treating cells with RNaseH removed the signal, validating the specificity of the S9.6 for the RNA structures (<xref ref-type="fig" rid="RSOB190222F4">figure 4</xref><italic>a</italic>(i),<italic>b</italic>(i)). The intensity ratio of the S9.6 signal in the nuclei to the DAPI signal, in both patient lymphoblast null cells and independently targeted HCT116 TOP3B null cells, was significantly higher than their respective controls. The results show that loss of TOP3B causes accumulation of R-loops that probably triggers the observed genomic instability, a consequence that predisposes cells to malignancy [<xref ref-type="bibr" rid="RSOB190222C39">39</xref>].
<fig id="RSOB190222F4" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Loss of TOP3B causes R-loop accumulation. (<italic>a</italic>) (i) Representative images of lymphoblasts (homozygous control, C; heterozygous parental controls, F, M; homozygous TOP3 null patient, P) and (ii) quantification of R-loop intensity. Significant differences were observed for C versus P, F versus P, M versus P, C versus F and C versus M (<italic>p</italic> &lt; 0.05), but not at F versus M (<italic>p</italic> &gt; 0.05). (<italic>b</italic>) (i) Representative images of wild-type HCT116 (HCT) and homozygous TOP3B null controls (Top3B_1.12 and Top3B_4.8) and (ii) quantification of R-loop intensity. R-loops were stained with the S9.6 antibody (green) and DNA with DAPI (blue). As a control, TOP3B null cells were treated with RNaseH, which disrupts R-loops and causes S9.6 staining to disappear, confirming the specificity of the antibody for R-loops. R-loop intensity was determined as S9.6 intensity relative to DAPI intensity. A significant increase for both the TOP3B null patient (top right) and HCT116 TOP3B null clones (bottom right) was observed. Data are from three independent experiments, with at least 200 cells measured at each experiment. Asterisk denotes <italic>p</italic> &lt; 0.05. Scale bar, 5 µm.</p></caption><graphic xlink:href="rsob-9-190222-g4"></graphic></fig></p>
<p>An interesting feature of patient analyses is that the heterozygote parents in certain assays showed an intermediate phenotype between control and null lymphoblasts. This was evident in our micronuclei and R-loop analyses (figures <xref ref-type="fig" rid="RSOB190222F2">2</xref><italic>a</italic> and <xref ref-type="fig" rid="RSOB190222F4">4</xref><italic>a</italic>). Immunoblotting showed there was a significant reduction of TOP3B protein in parent cells compared with wild-type control cells (<xref ref-type="fig" rid="RSOB190222F1">figure 1</xref><italic>b</italic>; electronic supplementary material, figure S1<italic>b</italic>), suggesting there could be a level of haploinsufficiency in the heterozygote cells.</p>
</sec>
<sec id="s2d">
<label>2.4.</label>
<title>TOP3B and the DNA damage response</title>
<p>Replication intermediates arising from incomplete or stalled replication are dealt with by various cellular pathways including non-homologous end joining (NHEJ) [<xref ref-type="bibr" rid="RSOB190222C40">40</xref>]. R-loops impair replication fork progression and induce replication stress [<xref ref-type="bibr" rid="RSOB190222C41">41</xref>]. Flow cytometry profiles showed that TOP3B null cells were not arrested in any particular cell cycle stage (electronic supplementary material, figure S1<italic>c</italic>). We tested whether TOP3B removal interferes with DNA damage pathways. The p53-binding protein 1 (53BP1) is a key component of the double-strand break signalling and repair pathway in mammals and promotes the pathway for NHEJ-mediated repair of double-stranded breaks (DSBs) [<xref ref-type="bibr" rid="RSOB190222C42">42</xref>]. An antibody recognizing 53BP1 was used to stain both HCT116 and HCT116 TOP3B null cells (<xref ref-type="fig" rid="RSOB190222F5">figure 5</xref><italic>a</italic>). Interestingly, null cells showed lower levels of 53BP1 than controls, suggesting this pathway is less active with repairing intrinsic replication stress. We then determined whether the repair itself was affected by analysing RAD51, a recombinase that plays a central role in the repair of DSBs via homologous recombination [<xref ref-type="bibr" rid="RSOB190222C43">43</xref>,<xref ref-type="bibr" rid="RSOB190222C44">44</xref>]. The level of RAD51 in null cells is heightened, consistent with the increase in DNA damage (<xref ref-type="fig" rid="RSOB190222F5">figure 5</xref><italic>b</italic>). BRCA1 is another protein involved in the repair of DSBs, but no difference was observed in BRCA1 intensity between null cells and control cells (<xref ref-type="fig" rid="RSOB190222F5">figure 5</xref><italic>c</italic>). BRCA1 counteracts 53BP1 by promoting DSB repair using homologous recombination instead of NHEJ [<xref ref-type="bibr" rid="RSOB190222C45">45</xref>,<xref ref-type="bibr" rid="RSOB190222C46">46</xref>]. Taken together, these results show that elements of the DSB repair signalling pathway are altered when TOP3B is perturbed, and suggest the DNA damage response, as a result of intrinsic replication stress, is diminished when TOP3B is deleted. Also, the homologous recombination pathway may be favoured over NHEJ to repair damaged DNA.
<fig id="RSOB190222F5" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Altered DNA damage response in HCT116 TOP3B-deficient cells. (<italic>a</italic>) (i) Representative images of cells stained for 53BP1 (red) and DNA (DAPI, blue). (ii) Quantification reveals a decrease in the intensity ratio of 53BP1 to DAPI in TOP3B null clones (Top3B_1.12 and Top3B_4.8) relative to control HCT116 cells (HCT). (<italic>b</italic>) (i) Representative images of cells stained for RAD51 (red) and DNA (DAPI, blue). (ii) Quantification reveals an increase in the intensity ratio of RAD51 to DAPI in TOP3B null clones relative to control HCT116. (<italic>c</italic>) (i) Representative images of cells stained for BRCA1 (green) and DNA (DAPI, blue). (ii) Quantification in the intensity ratio of BRCA1 to DAPI between control and TOP3B null cells. Data are from three independent experiments, with at least 200 cells measured for each experiment. Asterisk denotes <italic>p</italic> &lt; 0.05. n.s., no significant difference. Scale bar, 5 µm.</p></caption><graphic xlink:href="rsob-9-190222-g5"></graphic></fig></p>
<p>The 53BP1 signalling response in HCT116 TOP3B null cells appears to be lowered. We exposed cells to genotoxic stress and examined the checkpoint responses to further explore this result. HCT116 control and HCT116 TOP3B null cells were treated with replication inhibitors (i.e. thymidine or hydroxyurea) and the damage response was assessed with both γ-H2AX and phospho-P53 (<xref ref-type="fig" rid="RSOB190222F6">figure 6</xref><italic>a</italic>,<italic>b</italic>). Flow cytometry profiles showed that both control and null cells were arrested in G1/S with either thymidine or hydroxyurea treatment (electronic supplementary material, figure S2<italic>a</italic>). Consistent with earlier experiments, untreated HCT116 TOP3B null cells showed a greater increase in γ-H2AX than controls. However, the situation was reversed with HCT116 TOP3B null cells having a weaker response to DNA damage than controls when treated with thymidine or hydroxyurea (<xref ref-type="fig" rid="RSOB190222F6">figure 6</xref><italic>b</italic>(i)). At first glance this seems contradictory, but the response is stronger in wild-type cells than TOP3B null cells when treated with genotoxic agents, suggesting some compromise in the signal response. The higher level of DNA damage in untreated HCT116 TOP3B null cells reflects the fact that under normal circumstances, TOP3B-depleted cells accumulate more DNA damage. Phospho-P53 (Ser15) was used to examine downstream signalling of γ-H2AX. Phospho-P53 at Ser15 is used to amplify the checkpoint response signal. In untreated cells, levels of phospho-P53 were lower in TOP3B null clones than control cells (<xref ref-type="fig" rid="RSOB190222F6">figure 6</xref><italic>b</italic>(ii)). This difference was more pronounced in TOP3B null cells than parental control when treated with thymidine or hydroxyurea. Together, these results show that the removal of TOP3B has a deleterious effect on the DNA damage signalling mechanism.
<fig id="RSOB190222F6" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>DNA damage response of HCT116 TOP3B null cells treated with replication stress agents. (<italic>a</italic>) Representative images of HCT116 control (HCT) and TOP3B null clones (Top3B_1.12 and Top3B_4.8) untreated and treated with thymidine or hydroxyurea, co-stained for γ-H2AX (red) and phospho-P53 (green). (<italic>b</italic>) Quantification of the intensity ratio for (i) γ-H2AX to DAPI and (ii) phospho-P53 to DAPI on HCT116 control and HCT116 TOP3B null cells treated with thymidine or hydroxyurea. Data are from three independent experiments, with at least 200 cells measured for each experiment. Asterisk denotes <italic>p</italic> &lt; 0.05. n.s., no significant difference. Scale bar, 5 µm.</p></caption><graphic xlink:href="rsob-9-190222-g6"></graphic></fig></p>
<p>Despite having a perturbed checkpoint response, HCT116 TOP3B null cells still arrest when exposed to genotoxic stress (electronic supplementary material, figure S2<italic>a</italic>). To assess for recovery after genotoxic stress, cells were treated with thymidine, hydroxyurea or aphidicolin for 24 h, washed and allowed to recover for 7 days. Cells on plates were stained using crystal violet and the number of colony-forming clones was assessed. HCT116 control and HCT116 TOP3B<sup>−/−</sup> untreated cells showed little difference in colony forming after initially being seeded at equivalent amounts, indicating that the growth rate is not impaired as a result of TOP3B deficiency (<xref ref-type="fig" rid="RSOB190222F7">figure 7</xref><italic>a</italic>). This is consistent with our own TOP3B null patient who was of normal height and stature and also mice data that showed nulls develop normally to maturity [<xref ref-type="bibr" rid="RSOB190222C6">6</xref>]. However, HCT116 TOP3B null cells formed significantly less clones than controls after being treated with thymidine, hydroxyurea or aphidicolin and allowed to recover for 7 days (<xref ref-type="fig" rid="RSOB190222F7">figure 7</xref><italic>a</italic>). This further suggests that the repair mechanism is compromised in TOP3B-deficient cells. We assessed cells for micronuclei formation using the same treatment conditions. Consistent with earlier analyses (<xref ref-type="fig" rid="RSOB190222F2">figure 2</xref><italic>a</italic>), there was a slight increase in the amount of micronuclei in untreated HCT116 TOP3B null cells (TOP3B nulls cells versus control: 4.4–7.5% versus 3.5%). However, HCT116 TOP3B null cells treated with thymidine, hydroxyurea or aphidicolin showed a much greater percentage increase (thymidine: 19–24%; hydroxyurea: 17–26%; aphidicolin: 24–27%) in micronuclei relative to controls (thymidine: 10%; hydroxyurea: 11%; aphidicolin: 16%; <xref ref-type="fig" rid="RSOB190222F7">figure 7</xref><italic>b</italic>). Consistently, a very large increase in nuclei displaying DNA damage, as assessed by the appearance of γ-H2AX foci, was observed when HCT116 TOP3B null cells were allowed to recover (<xref ref-type="fig" rid="RSOB190222F7">figure 7</xref><italic>c</italic>). A large portion of cells retained three to four γ-H2AX foci when recovered from replication stress. Furthermore, more than 60% of cells displayed γ-H2AX foci in the micronuclei (electronic supplementary material, figure S2<italic>b</italic>). Heterogeneous DNA damage response was observed in cells recovered from replication stress (electronic supplementary material, figure S2<italic>c</italic>). Together, these results show TOP3B-deficient cells are more sensitive to genotoxic stress and DNA damage.
<fig id="RSOB190222F7" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Recovery after replication stress is impaired in TOP3B null cells. (<italic>a</italic>) (i) Representative images of crystal violet-stained plates from the colony-forming assay. HCT116 control (HCT) and HCT116 TOP3B null (Top3B_1.12 and Top3B_4.8) cells were treated with no drug, thymidine, hydroxyurea or aphidicolin and allowed to recover for seven days. (ii) Survival rate (%) of colony formation. Data are from three independent experiments, with each experimental sample done in triplicate or more. Asterisk denotes <italic>p</italic> &lt; 0.05. n.s., no significant difference. (<italic>b</italic>) (i) Representative DNA-stained (DAPI) images of micronuclei formation of HCT116 control and HCT116 TOP3B null cells treated with no drug, thymidine, hydroxyurea or aphidicolin and allowed to recover for 48 h. (ii) Quantification of micronuclei. Data are from three independent experiments, with at least 1000 cells scored at each experiment. (<italic>c</italic>) (i) Representative images of HCT116 control and HCT116 TOP3B null clones treated with no drug, thymidine, hydroxyurea or aphidicolin and allowed to recover for 48 h and stained for γ-H2AX (red) and DNA (DAPI, blue). (ii) Quantification of the number of γ-H2AX foci in each cell. Data are from three independent experiments, with at least 150 cells scored at each experiment. Scale bar, 5 µm.</p></caption><graphic xlink:href="rsob-9-190222-g7"></graphic></fig></p>
</sec>
</sec>
<sec id="s3">
<label>3.</label>
<title>Discussion</title>
<p>Our data provide the first direct <italic>in vivo</italic> evidence that TOP3B loss leads to increased R-loop formation. R-loops have gained considerable attention over the last decade and despite there being important benefits of R-loop formation in DNA replication, gene expression, class switch recombination and DNA repair, studies have shown excessive R-loop formation can lead to genome instability [<xref ref-type="bibr" rid="RSOB190222C11">11</xref>]. Available data suggest that DSBs can be formed by a collision between R-loops and the replication machinery [<xref ref-type="bibr" rid="RSOB190222C47">47</xref>,<xref ref-type="bibr" rid="RSOB190222C48">48</xref>]. Our hypothesis is that loss of TOP3B causes increased the formation of R-loops, which results in unresolved recombination intermediates that persist into mitosis and lead to genome instability.</p>
<sec id="s3a">
<label>3.1.</label>
<title>Loss of TOP3B causes genome instability</title>
<p>We found a corresponding increase in genome instability as a result of TOP3B deficiency. This result was consistently identified in our independently targeted HCT116 TOP3B null clones and patient TOP3B null lymphoblasts, strongly confirming our results. Micronuclei were mildly elevated across all cell lines in non-stressed patient TOP3B null lymphoblast cells. This argues for a slow accumulation of DNA damage over time and suggests that pathological defects such as cancer would be uncommon in less mature subjects. It is useful to contrast this with patients with Bloom syndrome, which similarly also show increased micronuclei and ultrafine bridges [<xref ref-type="bibr" rid="RSOB190222C33">33</xref>]. Mutations in the BLM gene lead to patients often being affected by cancers before they reach adulthood [<xref ref-type="bibr" rid="RSOB190222C49">49</xref>]. Why does TOP3B disruption not lead to early onset cancers similar to BTRR subunits disruption? Disruption of BTRR subunits and TOP3B causes a significant increase in UFBs and to a lesser extent bulky DNA bridges. However, only disruption of BTRR subunits [<xref ref-type="bibr" rid="RSOB190222C34">34</xref>,<xref ref-type="bibr" rid="RSOB190222C50">50</xref>–<xref ref-type="bibr" rid="RSOB190222C52">52</xref>] causes a dramatic rise in sister-chromatid exchange events, a process that carries an inherent mutability. We would predict those with mutated TOP3B would be likely to develop cancers much later in life, consistent with our patient first diagnosed at 49 years of age.</p>
</sec>
<sec id="s3b">
<label>3.2.</label>
<title>TOP3B disruption markedly increases R-loop formation and DNA damage</title>
<p>During development, cells are frequently exposed to a variety of environmental stresses. Therefore, cells have evolved elaborate surveillance mechanisms that allow them to transiently halt their progression through the cell cycle, maintain the arrest state and mount a response that should eventually lead to efficient recovery and resumption of the division cycle. Such mechanisms can coordinate the repair of DNA damage, the activation of cell cycle checkpoints to facilitate repair and apoptosis in order to eliminate cells with extensive DNA damage [<xref ref-type="bibr" rid="RSOB190222C53">53</xref>]. Thymidine depletes cellular pools of dCTP and causes replication fork stalling [<xref ref-type="bibr" rid="RSOB190222C54">54</xref>]; hydroxyurea inhibits the incorporation of nucleotides by interfering with enzyme ribonucleotide reductase and impedes replication [<xref ref-type="bibr" rid="RSOB190222C55">55</xref>,<xref ref-type="bibr" rid="RSOB190222C56">56</xref>]; aphidicolin interferes with DNA replication by inhibiting DNA polymerases <italic>α</italic>, ɛ and <italic>δ</italic> [<xref ref-type="bibr" rid="RSOB190222C57">57</xref>]. These genotoxic agents generate replication stress through different mechanisms, damaging DNA and result in the accumulation of γ-H2AX foci in the cells [<xref ref-type="bibr" rid="RSOB190222C58">58</xref>].</p>
<p>Our data show that TOP3B-depleted cells are much more likely to have DNA damage. This was seen in both null patient lymphoblasts and HCT116 TOP3B null cells. DNA damage increases the amount of problems observed in mitosis (e.g. a large rise in ultrafine bridges; <xref ref-type="fig" rid="RSOB190222F3">figure 3</xref>). Ultrafine bridges most frequently arise due to unresolved replication intermediates, which are probably caused by excessive R-loop formation [<xref ref-type="bibr" rid="RSOB190222C47">47</xref>,<xref ref-type="bibr" rid="RSOB190222C48">48</xref>]. Upon replication stress, TOP3B null cells have a weaker checkpoint response than wide type cells, suggesting a compromise in the cell cycle checkpoint control. This is consistent with a previous observation in <italic>Top3b</italic><sup>−/−</sup> murine embryonic fibroblasts [<xref ref-type="bibr" rid="RSOB190222C59">59</xref>]. Previous studies have indicated that the formation of micronuclei-staining positive for γ-H2AX is associated with DNA replication stress and irradiation-induced DSBs [<xref ref-type="bibr" rid="RSOB190222C32">32</xref>,<xref ref-type="bibr" rid="RSOB190222C60">60</xref>]. In this study, we observed increased numbers of cells with micronuclei with discrete γ-H2AX foci (electronic supplementary material, figure S1<italic>a</italic>), further demonstrating the presence of intrinsic replication stress in the TOP3B null cells.</p>
<p>Many proteins involved in DNA damage response and repair have been implicated in the regulation of R-loop accumulation. For example, RAD51 can promote R-loop-mediated DNA damage at R-loops sites, rather than repair DNA damage, leading to genome instability [<xref ref-type="bibr" rid="RSOB190222C61">61</xref>]. Patient and engineered TOP3B null cells both had a significant increase in R-loops (<xref ref-type="fig" rid="RSOB190222F4">figure 4</xref>), and our recovery experiments showed a greater increase in DNA damage in null cells after genotoxic stress (<xref ref-type="fig" rid="RSOB190222F7">figure 7</xref>). R-loops play a seemingly contradictory role in the DNA repair pathway. R-loops may promote DSB repair by facilitating homologous recombination and/or NHEJ [<xref ref-type="bibr" rid="RSOB190222C62">62</xref>,<xref ref-type="bibr" rid="RSOB190222C63">63</xref>]. However, R-loops can sequester BRCA1 binding to DSBs, thereby preventing DNA repair [<xref ref-type="bibr" rid="RSOB190222C64">64</xref>,<xref ref-type="bibr" rid="RSOB190222C65">65</xref>]. In this study, 53BP1 (NHEJ pathway) levels decreased and RAD51 (homologous recombination pathway) levels significantly increased in HCT116 TOP3B null cells, while levels of BRCA1 foci formation remained unchanged. BRCA1 is a main factor in homologous recombination repair in G2/S, but evidence also indicate that it is involved in NHEJ in G1 [<xref ref-type="bibr" rid="RSOB190222C66">66</xref>]. Our results suggest the homologous recombination pathway is activated in response to DSBs in HCT116 TOP3B null cells and preferred over NHEJ as expected in G2/M. A further interesting result is the lower level of phospho-P53 in TOP3B null cells relative to controls, particularly in stressed cells (<xref ref-type="fig" rid="RSOB190222F6">figure 6</xref>). In cells recovered from replication stress, a heterogeneous DNA damage response was observed, with phosphoP53 found to be dislocated from micronuclei displaying γ-H2AX foci (electronic supplementary material, figure S2<italic>c</italic>), suggesting that the DNA damage response in micronuclei is defective [<xref ref-type="bibr" rid="RSOB190222C32">32</xref>]. Taken together, these data indicate that TOP3B deletion might also compromise the DNA repair signalling mechanism. The mechanism of TOP3B in DNA repair is an important task for future investigations.</p>
</sec>
<sec id="s3c">
<label>3.3.</label>
<title>TOP3B and neural defects</title>
<p>The case for TOP3B playing a role in neurogenesis is strong with studies in fly and mice showing neural defects as a result of TOP3B disruption [<xref ref-type="bibr" rid="RSOB190222C23">23</xref>] and human TOP3B disrupted patients are predisposed to autism and schizophrenia [<xref ref-type="bibr" rid="RSOB190222C22">22</xref>]. TOP3B is enriched at multiple mRNAs with neural functions related to autism and schizophrenia [<xref ref-type="bibr" rid="RSOB190222C23">23</xref>]. Our data show increased baseline levels of γ-H2AX in unstressed cells (<xref ref-type="fig" rid="RSOB190222F2">figure 2</xref><italic>b</italic>), but a reduced response in TOP3B null cells treated with genotoxic agents (<xref ref-type="fig" rid="RSOB190222F6">figure 6</xref>). This, at first glance, seems paradoxical. Nevertheless, a search of the literature shows this trend is strikingly mirrored in multiple studies with cells exposed to DNA damage from schizophrenia patients [<xref ref-type="bibr" rid="RSOB190222C67">67</xref>–<xref ref-type="bibr" rid="RSOB190222C70">70</xref>]. However, our TOP3B-deficient patient displays no mental illness. This could be explained by the well-described environmental and multigenic events needed for the onset of these mental conditions.</p>
</sec>
<sec id="s3d">
<label>3.4.</label>
<title>TOP3B and cancer</title>
<p>R-loop processing is gaining more attention in relation to cancer [<xref ref-type="bibr" rid="RSOB190222C11">11</xref>]. Our own bioinformatic analyses show a marked increase in homozygous deletions of TOP3B in a broad range of cancer somatic tissues (tables <xref ref-type="table" rid="RSOB190222TB1">1</xref> and <xref ref-type="table" rid="RSOB190222TB2">2</xref>). The link between TOP3B, R-loops and cancer is telling. R-loop formation can increase DSBs, which can, in turn, lead to chromosome translocations or genome instability. Excessive R-loops can also alter gene expression. Therefore, potential tumour suppressor or DNA repair genes could be negatively affected in cells without TOP3B. This is a very interesting new area and we believe over time TOP3B will be added to the list of causative cancer genes.</p>
</sec>
</sec>
<sec id="s4" sec-type="methods">
<label>4.</label>
<title>Material and methods</title>
<sec id="s4a">
<label>4.1.</label>
<title>Subjects</title>
<p>Written consent was obtained from family members used in this research study as part of the Austin Health Adult Undiagnosed Diseases Program, according to Austin Health policies. The ethic number is AU RED HREC Reference Number: HREC/18/Austin/41.</p>
</sec>
<sec id="s4b">
<label>4.2.</label>
<title>Genomic microarray</title>
<p>Purified genomic DNA samples were processed by the Illumina Infinium method and were hybridized onto Infinium Omni2.5 v1.2 SNP-array chip (Illumina). Data were analysed with K<sc>aryo</sc>S<sc>tudio</sc> v1.4 software (Illumina).</p>
</sec>
<sec id="s4c">
<label>4.3.</label>
<title>Cell lines</title>
<p>Lymphoblasts were obtained from wild-type TOP3B normal (GM19238, Coriell), heterozygous TOP3B<sup>+/−</sup> parental (mother and father) and a homozygous null TOP3B patient. The near diploid human colorectal cell line HCT116 was engineered to be homozygous null TOP3 using two separate guide RNAs, thereby producing two independently targeted TOP3B null lines (see below). All cell lines were maintained RPMI medium supplemented with 10% fetal bovine serum and penicillin–streptomycin, as described before [<xref ref-type="bibr" rid="RSOB190222C34">34</xref>]. All cells grew in incubators with a humidified atmosphere containing 5% CO<sub>2</sub> and 95% air at 37°C.</p>
</sec>
<sec id="s4d">
<label>4.4.</label>
<title>Replication stress</title>
<p>Cells were treated for 24 h with thymidine (2 mM), hydroxyurea (2 mM) or aphidicolin (0.5 µg ml<sup>−1</sup>) to induce replication stress. For recovery experiments, cells were washed with PBS and incubated in the normal medium for another 48 h after stress induction before being harvested for immunofluorescent staining or grown for seven days for the colony-forming assay.</p>
</sec>
<sec id="s4e">
<label>4.5.</label>
<title>Immunofluorescence microscopy and image analysis</title>
<p>For immunofluorescence staining, HCT116 cells grown on cover slides or lymphoblast cells pre-seeded on poly-<sc>l</sc>-lysine-coated slides were fixed with 4% paraformaldehyde (PFA) for 10 min, permeabilized with 0.3% triton-X100 and blocked with 3% BSA in PBS. Cells were stained with rabbit polyclonal anti-γ-H2A.X (phosopho S139) (1 : 800) (Abcam), mouse monoclonal anti-PICH (1 : 200) (Millipore), mouse monoclonal anti-53BP1 (1 : 400) (Millipore), mouse monoclonal anti-phospho-p53 (Ser15) (1 : 400) (CST) or mouse monoclonal anti-Lamin A/C (1 : 200) (Chemicon). Secondary antibodies were donkey anti-rabbit Alexa Fluor 488 (1 : 1000) (Invitrogen) or goat anti-mouse Alex Fluor 594 (1 : 1000) (Invitrogen). R-loop staining was performed as described by Schwab <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB190222C71">71</xref>] with slight modifications. Cells were pre-extracted with 0.5% triton-X100 before fixation with 4% PFA. After permeabilization, cells were incubated with 125 µg ml<sup>−1</sup> RNase A at 37°C for 2 h. For negative controls, cells were further incubated with 0.05 U µl<sup>−1</sup> RNase H (BioLabs) at 37°C for 4 h. Cells were then blocked with 5% BSA in PBS at room temperature for 2 h before being stained with mouse monoclonal anti-R-loop (S9.6) antibody (1 : 100) (a gift from Dr Andrew Deans, St Vincent's Institute, Melbourne, Australia) at room temperature for 2 h. Cells were mounted with Vectashield mounting medium containing DAPI (Vetor Laboratories).</p>
<p>Images were acquired with a Delta Vision widefield deconvolution microscope. Forty-eight section (0.2 µm per section) images with 20× or 40× objective lens were taken and processed by S<sc>oft</sc>W<sc>o</sc>R<sc>x</sc> 4.1. Cells were further analysed by IMARIS 8.1.2 for immunofluorescence intensity measurements. For intensity measurement, three independent experiments were conducted and at least 150 cells in each experiment were measured. Arbitrary intensity units of Alex488 or Alex594 to DAPI were plotted.</p>
</sec>
<sec id="s4f">
<label>4.6.</label>
<title>Immunoblotting</title>
<p>Immunoblotting was conducted as described [<xref ref-type="bibr" rid="RSOB190222C72">72</xref>]. In brief, cells were resuspended in RIPA with fresh prepared EDTA-free protease inhibitor (Roche) and incubated on ice for 15 min, followed by sonication. Forty micrograms protein from each sample was subjected to 7.5% SDS–PAGE gels. Primary antibodies were rabbit monoclonal anti-TOP3B (1 : 500) (Abcam) or mouse monoclonal anti-TOP3B (1 : 250) (Santa Cruz Biotechnology) or mouse monoclonal anti-α-tubulin (1 : 1000) (Sigma). Secondary antibodies were anti-rabbit IgG-HRP (1 : 10 000) (Amersham) or anti-mouse IgG-HRP (1 : 10 000) (Amersham). Western Blotting Luminol Reagent (Santa Cruz Biotechnology) was used according to the manufacturer's instructions. Intensity was measured by Fiji distribution of ImageJ.</p>
</sec>
<sec id="s4g">
<label>4.7.</label>
<title>Flow cytometry</title>
<p>FACS analysis was performed, as described in [<xref ref-type="bibr" rid="RSOB190222C72">72</xref>], and analysed using FCS express 6.06.</p>
</sec>
<sec id="s4h">
<label>4.8.</label>
<title>Colony-forming assay</title>
<p>The colony-forming assay was conducted, as described by Crowley <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB190222C73">73</xref>]. In brief, 300 cells/well were seeded in triplicate on 6-well-plates for each sample. After treatment with thymidine, hydroxyurea or aphidicolin for 24 h, cells were washed and allowed to recover for 7 days. After 7 days, 6-well-plates were placed on ice and wash 2× with ice-cold PBS. Cells were fixed with ice-cold methanol for 10 min and stained with a crystal violet staining solution for 5 min at room temperature. The plates were carefully rinsed with ddH<sub>2</sub>O and allowed to dry at room temperature overnight before imaging. Colonies were counted by Fiji distribution of I<sc>mage</sc>J with colony_counter.jar plugin (<uri xlink:href="https://imagej.nih.gov/ij/plugins/colony-counter.html">https://imagej.nih.gov/ij/plugins/colony-counter.html</uri>). Survival rate = colony numbers/300.</p>
</sec>
<sec id="s4i">
<label>4.9.</label>
<title>Statistical analyses</title>
<p>Box plots and bar charts were generated using beeswarm R package (<uri xlink:href="https://cran.rproject.org/web/packages/beeswarm/index.html">https://cran.rproject.org/web/packages/beeswarm/index.html</uri>) or gplots (<uri xlink:href="https://cran.r-project.org/web/packages/gplots/index.html">https://cran.r-project.org/web/packages/gplots/index.html</uri>). Statistical analyses were conducted using Student's <italic>t</italic>-test (unpaired). <italic>P</italic>-values less than 0.05 were considered as indicating statistically significant differences. Error bars represent SEM.</p>
</sec>
<sec id="s4j">
<label>4.10.</label>
<title>CRISPR–Cas9 knockout</title>
<p>Two independent nicking CRISPR–Cas9 guide pairs were designed using the CRISPR design tool at crispr.mit.edu. Both pairs targeted the coding sequence of exon 6 of the TOP3B gene (NM_001282112.2). The following target sites for nicking pair no. 1, Guide A minus (5'–GAGAGCGCCTCGTTGTGGTCAGG-3'), Guide B plus (5'-CAGGAGCTGGACCTGCGAATCGG-3'), and no. 4 Guide A minus (5'-CCACTGAGAGCGCCTCGTTGTGG-3'), Guide B plus (5'–GAATCGGCTGTGCATTCACCAGG-3'). Annealed oligonucleotides were cloned into the pSpCas9n (BB)-2A-GFP (PX461) vector (Addgene plasmid ID: 48140) [<xref ref-type="bibr" rid="RSOB190222C74">74</xref>]. HCT116 cells were transfected in 6-well trays with Lipofectamine 3000 (Thermo Fisher Scientific) using the supplier's protocol. Two days after transfection, GFP-positive single cells were sorted by FACS into 96-well trays. Genomic DNA from clones was extracted using standard methods followed by PCR amplification screening across the CRISPR target site using the following oligonucleotides; TB3-mf (5'-GTCACAGCTGGCCACTCC-3') TB3-mr (5'-GAGGGGGACCAGTAGAGG-3'). PCR products were cloned into pGEM-T Easy (Promega) and Sanger sequenced at the Australian Genome Research Facility to confirm the presence of a knockout mutation. Three clones with knockout alleles at the DNA and protein levels were chosen for functional characterization.</p>
</sec>
<sec id="s4k">
<label>4.11.</label>
<title>Sister-chromatid exchange assay</title>
<p>Fresh blood cells were incubated for three to four days in RPMI 1640 medium/10% FBS with 20 µg ml<sup>−1</sup> phytohaemagglutin. BrdU (Sigma-Aldrich) was added to a final concentration of 10 µg ml<sup>−1</sup> for 30 h followed by 0.1 mg ml<sup>−1</sup> colcemid (Thermo Fischer Scientific) treatment for 45 min before standard metaphase chromosome harvest. Phosphate buffer pH 6.8 was added to cover the dried slides to a depth of 2 mm. Slides were then placed in a biosafety cabinet and were exposed to UV light at a distance of 30 cm for 45 min. The slides were briefly rinsed in dH<sub>2</sub>O and added to prewarmed 2×SSC at 65°C for 30 min, followed by another rinse in dH<sub>2</sub>O and stained in Leishman's stain (Sigma-Aldrich).</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<caption>
<title>Figure S1</title>
</caption>
<media id="d35e1706" mime-subtype="pdf" mimetype="application" orientation="portrait" position="anchor" xlink:href="rsob190222supp1.pdf"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="d35e223">
<caption>
<title>Reviewer comments</title>
</caption>
<media mime-subtype="pdf" mimetype="application" xlink:href="rsob190222_review_history.pdf"></media>
</supplementary-material>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD2">
<caption>
<title>Figure S2</title>
</caption>
<media id="d35e1714" mime-subtype="pdf" mimetype="application" orientation="portrait" position="anchor" xlink:href="rsob190222supp2.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to Dr Andrew Deans (St Vincent's Institute) for the S9.6 antibody and R-loop immunofluorescence staining protocol and Kathy Butler (VCGS) for performing sister-chromatid exchanges assays.</p>
</ack>
<sec id="s5">
<title>Ethics</title>
<p>Written consent was obtained from the family members used in this research study as part of the Austin Health Adult Undiagnosed Diseases Program, according to Austin Health policies. The ethic number is AU RED HREC Reference Number: HREC/18/Austin/41.</p>
</sec>
<sec id="s6">
<title>Data accessibility</title>
<p>This article does not contain any additional data.</p>
</sec>
<sec id="s7">
<title>Authors' contributions</title>
<p>D.F.H. helped conceive, plan experiments and wrote the manuscript. T.Z. helped conceive and performed all cell biology experiments, data analyses and contributed to the manuscript. P.K. helped conceive experiments and generated CRISPR lines, bioinformatic analyses and contributed to the manuscript. M.W. provided clinical data and contributed to the manuscript. V.P. and J.C. performed the microarray analyses.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Competing interests</title>
<p>We declare we have no competing interests.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>Funding was provided by the National Health and Medical Research Council (Australia) project grants nos. GNT1127209 (P.K. and D.F.H.) and GNT1145188 (P.K. and D.F.H.) and by the Victorian Government's Operational Infrastructure Support Program.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="RSOB190222C1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name></person-group>
<year>2017</year>
<article-title>Type IA topoisomerases can be ‘magicians’ for both DNA and RNA in all domains of life</article-title>. <source/>RNA Biol.
<volume>14</volume>, <fpage>854</fpage>–<lpage>864</lpage>. (<pub-id pub-id-type="doi">10.1080/15476286.2017.1330741</pub-id>)<pub-id pub-id-type="pmid">28534707</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forterre</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gadelle</surname><given-names>D</given-names></name></person-group>
<year>2009</year>
<article-title>Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms</article-title>. <source/>Nucleic Acids Res.
<volume>37</volume>, <fpage>679</fpage>–<lpage>692</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkp032</pub-id>)<pub-id pub-id-type="pmid">19208647</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bizard</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Hickson</surname><given-names>ID</given-names></name></person-group>
<year>2014</year>
<article-title>The dissolution of double Holliday junctions</article-title>. <source/>Cold Spring Harbor Perspect. Biol.
<volume>6</volume>, <fpage>a016477</fpage> (<pub-id pub-id-type="doi">10.1101/cshperspect.a016477</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB190222C4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bachrati</surname><given-names>CZ</given-names></name>, <name name-style="western"><surname>Hickson</surname><given-names>ID</given-names></name></person-group>
<year>2009</year>
<article-title>Dissolution of double Holliday junctions by the concerted action of BLM and topoisomerase IIIalpha</article-title>. <source/>Methods Mol Biol.
<volume>582</volume>, <fpage>91</fpage>–<lpage>102</lpage>. (<pub-id pub-id-type="doi">10.1007/978-1-60761-340-4_8</pub-id>)<pub-id pub-id-type="pmid">19763944</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JC</given-names></name></person-group>
<year>1998</year>
<article-title>Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis</article-title>. <source/>Pro.c Natl Acad. Sci. USA
<volume>95</volume>, <fpage>1010</fpage>–<lpage>1013</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.95.3.1010</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB190222C6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwan</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JC</given-names></name></person-group>
<year>2001</year>
<article-title>Mice lacking DNA topoisomerase IIIβ develop to maturity but show a reduced mean lifespan</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>98</volume>, <fpage>5717</fpage>–<lpage>5721</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.101132498</pub-id>)<pub-id pub-id-type="pmid">11331780</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwan</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Moens</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JC</given-names></name></person-group>
<year>2003</year>
<article-title>Infertility and aneuploidy in mice lacking a type IA DNA topoisomerase IIIβ</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>100</volume>, <fpage>2526</fpage>–<lpage>2531</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0437998100</pub-id>)<pub-id pub-id-type="pmid">12591952</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson-Sali</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>TS</given-names></name></person-group>
<year>2002</year>
<article-title>Preferential cleavage of plasmid-based R-loops and D-loops by <italic>Drosophila</italic> topoisomerase IIIβ</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>99</volume>, <fpage>7974</fpage>–<lpage>7979</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.122007999</pub-id>)<pub-id pub-id-type="pmid">12048241</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name></person-group>
<year>2017</year>
<article-title>Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>2704</fpage>–<lpage>2713</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkw1293</pub-id>)<pub-id pub-id-type="pmid">28039324</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plank</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Pohlhaus</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Wilson-Sali</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>TS</given-names></name></person-group>
<year>2005</year>
<article-title><italic>Drosophila melanogaster</italic> topoisomerase IIIalpha preferentially relaxes a positively or negatively supercoiled bubble substrate and is essential during development</article-title>. <source/>J. Biol. Chem.
<volume>280</volume>, <fpage>3564</fpage>–<lpage>3573</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M411337200</pub-id>)<pub-id pub-id-type="pmid">15537633</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sollier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cimprich</surname><given-names>KA</given-names></name></person-group>
<year>2015</year>
<article-title>Breaking bad: R-loops and genome integrity</article-title>. <source/>Trends Cell Biol.
<volume>25</volume>, <fpage>514</fpage>–<lpage>522</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tcb.2015.05.003</pub-id>)<pub-id pub-id-type="pmid">26045257</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piazza</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Heyer</surname><given-names>WD</given-names></name></person-group>
<year>2019</year>
<article-title>Moving forward one step back at a time: reversibility during homologous recombination</article-title>. <source/>Current genetics.
<volume>65</volume>, <fpage>1333</fpage>–<lpage>1340</lpage>. (<pub-id pub-id-type="doi">10.1007/s00294-019-00995-7</pub-id>)<pub-id pub-id-type="pmid">31123771</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drolet</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Phoenix</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Menzel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Masse</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Crouch</surname><given-names>RJ</given-names></name></person-group>
<year>1995</year>
<article-title>Overexpression of RNase H partially complements the growth defect of an <italic>Escherichia coli</italic> delta topA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>92</volume>, <fpage>3526</fpage>–<lpage>3530</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.92.8.3526</pub-id>)<pub-id pub-id-type="pmid">7536935</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stolz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sulthana</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hartono</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Malig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Benham</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Chedin</surname><given-names>F</given-names></name></person-group>
<year>2019</year>
<article-title>Interplay between DNA sequence and negative superhelicity drives R-loop structures</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>116</volume>, <fpage>6260</fpage>–<lpage>6269</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1819476116</pub-id>)<pub-id pub-id-type="pmid">30850542</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Lieber</surname><given-names>MR</given-names></name></person-group>
<year>2010</year>
<article-title>Competition between the RNA transcript and the nontemplate DNA strand during R-loop formation in vitro: a nick can serve as a strong R-loop initiation site</article-title>. <source/>Mol. Cell. Biol.
<volume>30</volume>, <fpage>146</fpage>–<lpage>159</lpage>. (<pub-id pub-id-type="doi">10.1128/mcb.00897-09</pub-id>)<pub-id pub-id-type="pmid">19841062</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skourti-Stathaki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Proudfoot</surname><given-names>NJ</given-names></name></person-group>
<year>2014</year>
<article-title>A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression</article-title>. <source/>Genes Dev.
<volume>28</volume>, <fpage>1384</fpage>–<lpage>1396</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.242990.114</pub-id>)<pub-id pub-id-type="pmid">24990962</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ginno</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Lott</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Korf</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Chedin</surname><given-names>F</given-names></name></person-group>
<year>2012</year>
<article-title>R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters</article-title>. <source/>Mol Cell.
<volume>45</volume>, <fpage>814</fpage>–<lpage>825</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2012.01.017</pub-id>)<pub-id pub-id-type="pmid">22387027</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ginno</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Lott</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Korf</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Chedin</surname><given-names>F</given-names></name></person-group>
<year>2013</year>
<article-title>GC skew at the 5' and 3' ends of human genes links R-loop formation to epigenetic regulation and transcription termination</article-title>. <source/>Genome Res.
<volume>23</volume>, <fpage>1590</fpage>–<lpage>1600</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.158436.113</pub-id>)<pub-id pub-id-type="pmid">23868195</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skourti-Stathaki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Proudfoot</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Gromak</surname><given-names>N</given-names></name></person-group>
<year>2011</year>
<article-title>Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination</article-title>. <source/>Mol. Cell
<volume>42</volume>, <fpage>794</fpage>–<lpage>805</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2011.04.026</pub-id>)<pub-id pub-id-type="pmid">21700224</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguilera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Garcia-Muse</surname><given-names>T</given-names></name></person-group>
<year>2012</year>
<article-title>R loops: from transcription byproducts to threats to genome stability</article-title>. <source/>Mol. Cell
<volume>46</volume>, <fpage>115</fpage>–<lpage>124</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2012.04.009</pub-id>)<pub-id pub-id-type="pmid">22541554</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>McBride</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Hensley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chedin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bedford</surname><given-names>MT</given-names></name></person-group>
<year>2014</year>
<article-title>Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation</article-title>. <source/>Mol. Cell
<volume>53</volume>, <fpage>484</fpage>–<lpage>497</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2014.01.011</pub-id>)<pub-id pub-id-type="pmid">24507716</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoll</surname><given-names>G</given-names></name><etal>et al</etal></person-group><italic>.</italic>
<year>2013</year>
<article-title>Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1228</fpage>–<lpage>1237</lpage>. (<pub-id pub-id-type="doi">10.1038/nn.3484</pub-id>)<pub-id pub-id-type="pmid">23912948</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><etal>et al</etal></person-group><italic>.</italic>
<year>2013</year>
<article-title>Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1238</fpage>–<lpage>1247</lpage>. (<pub-id pub-id-type="doi">10.1038/nn.3479</pub-id>)<pub-id pub-id-type="pmid">23912945</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SK</given-names></name><etal>et al</etal></person-group><italic>.</italic>
<year>2018</year>
<article-title>Topoisomerase 3β interacts with RNAi machinery to promote heterochromatin formation and transcriptional silencing in <italic>Drosophila</italic></article-title>. <source/>Nat. Commun.
<volume>9</volume>, <fpage>4946</fpage> (<pub-id pub-id-type="doi">10.1038/s41467-018-07101-4</pub-id>)<pub-id pub-id-type="pmid">30470739</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiklund</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Tretli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Choueiri</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Signoretti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fall</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Adami</surname><given-names>HO</given-names></name></person-group>
<year>2009</year>
<article-title>Risk of bilateral renal cell cancer</article-title>. <source/>J. Clin. Oncol.
<volume>27</volume>, <fpage>3737</fpage>–<lpage>3741</lpage>. (<pub-id pub-id-type="doi">10.1200/jco.2008.20.6524</pub-id>)<pub-id pub-id-type="pmid">19597028</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudbjartsson</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2002</year>
<article-title>A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas</article-title>. <source/>Int. J. Cancer
<volume>100</volume>, <fpage>476</fpage>–<lpage>479</lpage>. (<pub-id pub-id-type="doi">10.1002/ijc.10513</pub-id>)<pub-id pub-id-type="pmid">12115533</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufman</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Genovese</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>MG</given-names></name></person-group>
<year>2016</year>
<article-title>Deletion of TOP3B Is associated with cognitive impairment and facial dysmorphism</article-title>. <source/>Cytogenet. Genome Res.
<volume>150</volume>, <fpage>106</fpage>–<lpage>111</lpage>. (<pub-id pub-id-type="doi">10.1159/000452815</pub-id>)<pub-id pub-id-type="pmid">27880953</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daghsni</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>TOP3B: a novel candidate gene in juvenile myoclonic epilepsy?</article-title>
<source/>Cytogenet. Genome Res.
<volume>154</volume>, <fpage>1</fpage>–<lpage>5</lpage>. (<pub-id pub-id-type="doi">10.1159/000486945</pub-id>)<pub-id pub-id-type="pmid">29490292</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>GM</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>A copy number variation morbidity map of developmental delay</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>838</fpage>–<lpage>846</lpage>. (<pub-id pub-id-type="doi">10.1038/ng.909</pub-id>)<pub-id pub-id-type="pmid">21841781</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coe</surname><given-names>BP</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Refining analyses of copy number variation identifies specific genes associated with developmental delay</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>1063</fpage>–<lpage>1071</lpage>. (<pub-id pub-id-type="doi">10.1038/ng.3092</pub-id>)<pub-id pub-id-type="pmid">25217958</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciccia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Elledge</surname><given-names>SJ</given-names></name></person-group>
<year>2010</year>
<article-title>The DNA damage response: making it safe to play with knives</article-title>. <source/>Mol. Cell
<volume>40</volume>, <fpage>179</fpage>–<lpage>204</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.019</pub-id>)<pub-id pub-id-type="pmid">20965415</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terradas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tusell</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Genesca</surname><given-names>A</given-names></name></person-group>
<year>2009</year>
<article-title>DNA lesions sequestered in micronuclei induce a local defective-damage response</article-title>. <source/>DNA Repair (Amst)
<volume>8</volume>, <fpage>1225</fpage>–<lpage>1234</lpage>. (<pub-id pub-id-type="doi">10.1016/j.dnarep.2009.07.004</pub-id>)<pub-id pub-id-type="pmid">19683478</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>North</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Hickson</surname><given-names>ID</given-names></name></person-group>
<year>2007</year>
<article-title>BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges</article-title>. <source/>Embo. J.
<volume>26</volume>, <fpage>3397</fpage>–<lpage>3409</lpage>. (<pub-id pub-id-type="doi">10.1038/sj.emboj.7601777</pub-id>)<pub-id pub-id-type="pmid">17599064</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hudson</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Amor</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Boys</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kalitsis</surname><given-names>P</given-names></name></person-group>
<year>2016</year>
<article-title>Loss of RMI2 increases genome instability and causes a bloom-like syndrome</article-title>. <source/>PLoS Genet.
<volume>12</volume>, <fpage>e1006483</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1006483</pub-id>)<pub-id pub-id-type="pmid">27977684</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Hickson</surname><given-names>ID</given-names></name></person-group>
<year>2014</year>
<article-title>The origins and processing of ultra fine anaphase DNA bridges</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>26</volume>, <fpage>1</fpage>–<lpage>5</lpage>. (<pub-id pub-id-type="doi">10.1016/j.gde.2014.03.003</pub-id>)<pub-id pub-id-type="pmid">24795279</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boguslawski</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Michalak</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mickelson</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Yehle</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Carrico</surname><given-names>RJ</given-names></name></person-group>
<year>1986</year>
<article-title>Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids</article-title>. <source/>J. Immunol. Methods
<volume>89</volume>, <fpage>123</fpage>–<lpage>130</lpage>. (<pub-id pub-id-type="doi">10.1016/0022-1759(86)90040-2</pub-id>)<pub-id pub-id-type="pmid">2422282</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Storz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gottesman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Leppla</surname><given-names>SH</given-names></name></person-group>
<year>2006</year>
<article-title>An antibody-based microarray assay for small RNA detection</article-title>. <source/>Nucleic Acids Res.
<volume>34</volume>, <fpage>e52</fpage> (<pub-id pub-id-type="doi">10.1093/nar/gkl142</pub-id>)<pub-id pub-id-type="pmid">16614443</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Hage</surname><given-names>A</given-names></name>, <name name-style="western"><surname>French</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Beyer</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Tollervey</surname><given-names>D</given-names></name></person-group>
<year>2010</year>
<article-title>Loss of Topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis</article-title>. <source/>Genes Dev.
<volume>24</volume>, <fpage>1546</fpage>–<lpage>1558</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.573310</pub-id>)<pub-id pub-id-type="pmid">20634320</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanahan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>RA</given-names></name></person-group>
<year>2011</year>
<article-title>Hallmarks of cancer: the next generation</article-title>. <source/>Cell
<volume>144</volume>, <fpage>646</fpage>–<lpage>674</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>)<pub-id pub-id-type="pmid">21376230</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>HHY</given-names></name>, <name name-style="western"><surname>Pannunzio</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Adachi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lieber</surname><given-names>MR</given-names></name></person-group>
<year>2017</year>
<article-title>Non-homologous DNA end joining and alternative pathways to double-strand break repair</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>18</volume>, <fpage>495</fpage>–<lpage>506</lpage>. (<pub-id pub-id-type="doi">10.1038/nrm.2017.48</pub-id>)<pub-id pub-id-type="pmid">28512351</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gui</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group>
<year>2011</year>
<article-title>R-loop-mediated genomic instability is caused by impairment of replication fork progression</article-title>. <source/>Genes Dev.
<volume>25</volume>, <fpage>2041</fpage>–<lpage>2056</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.17010011</pub-id>)<pub-id pub-id-type="pmid">21979917</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panier</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Boulton</surname><given-names>SJ</given-names></name></person-group>
<year>2014</year>
<article-title>Double-strand break repair: 53BP1 comes into focus</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>15</volume>, <fpage>7</fpage>–<lpage>18</lpage>. (<pub-id pub-id-type="doi">10.1038/nrm3719</pub-id>)<pub-id pub-id-type="pmid">24326623</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinohara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>T</given-names></name></person-group>
<year>1992</year>
<article-title>Rad51 protein involved in repair and recombination in <italic>S. cerevisiae</italic> is a RecA-like protein</article-title>. <source/>Cell
<volume>69</volume>, <fpage>457</fpage>–<lpage>470</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(92)90447-K</pub-id>)<pub-id pub-id-type="pmid">1581961</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinohara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Matsuda</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ushio</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ikeo</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>T</given-names></name></person-group>
<year>1993</year>
<article-title>Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA</article-title>. <source/>Nat. Genet.
<volume>4</volume>, <fpage>239</fpage>–<lpage>243</lpage>. (<pub-id pub-id-type="doi">10.1038/ng0793-239</pub-id>)<pub-id pub-id-type="pmid">8358431</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouwman</surname><given-names>P</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>17</volume>, <fpage>688</fpage>–<lpage>695</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb.1831</pub-id>)<pub-id pub-id-type="pmid">20453858</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunting</surname><given-names>SF</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks</article-title>. <source/>Cell
<volume>141</volume>, <fpage>243</fpage>–<lpage>254</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2010.03.012</pub-id>)<pub-id pub-id-type="pmid">20362325</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahba</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Amon</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Koshland</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vuica-Ross</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>RNase H and multiple RNA biogenesis factors cooperate to prevent RNA:DNA hybrids from generating genome instability</article-title>. <source/>Mol. Cell
<volume>44</volume>, <fpage>978</fpage>–<lpage>988</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2011.10.017</pub-id>)<pub-id pub-id-type="pmid">22195970</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stirling</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Minaker</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Aristizabal</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Barrett</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sipahimalani</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kobor</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Hieter</surname><given-names>P</given-names></name></person-group>
<year>2012</year>
<article-title>R-loop-mediated genome instability in mRNA cleavage and polyadenylation mutants</article-title>. <source/>Genes Dev.
<volume>26</volume>, <fpage>163</fpage>–<lpage>175</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.179721.111</pub-id>)<pub-id pub-id-type="pmid">22279048</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>German</surname><given-names>J</given-names></name></person-group>
<year>1997</year>
<article-title>Bloom's syndrome. XX. The first 100 cancers</article-title>. <source/>Cancer Genet. Cytogenet.
<volume>93</volume>, <fpage>100</fpage>–<lpage>106</lpage>. (<pub-id pub-id-type="doi">10.1016/S0165-4608(96)00336-6</pub-id>)<pub-id pub-id-type="pmid">9062585</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaganti</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Schonberg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>German</surname><given-names>J</given-names></name></person-group>
<year>1974</year>
<article-title>A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>71</volume>, <fpage>4508</fpage>–<lpage>4512</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.71.11.4508</pub-id>)<pub-id pub-id-type="pmid">4140506</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sobeck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Meetei</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Hoatlin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name></person-group>
<year>2005</year>
<article-title>BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity</article-title>. <source/>EMBO J.
<volume>24</volume>, <fpage>1465</fpage>–<lpage>1476</lpage>. (<pub-id pub-id-type="doi">10.1038/sj.emboj.7600622</pub-id>)<pub-id pub-id-type="pmid">15775963</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>CA</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Mutations in TOP3A cause a bloom syndrome-like disorder</article-title>. <source/>Am. J. Hum. Genet.
<volume>103</volume>, <fpage>221</fpage>–<lpage>231</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ajhg.2018.07.001</pub-id>)<pub-id pub-id-type="pmid">30057030</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Elledge</surname><given-names>SJ</given-names></name></person-group>
<year>2000</year>
<article-title>The DNA damage response: putting checkpoints in perspective</article-title>. <source/>Nature
<volume>408</volume>, <fpage>433</fpage>–<lpage>439</lpage>. (<pub-id pub-id-type="doi">10.1038/35044005</pub-id>)<pub-id pub-id-type="pmid">11100718</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolderson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Scorah</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Helleday</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Smythe</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Meuth</surname><given-names>M</given-names></name></person-group>
<year>2004</year>
<article-title>ATM is required for the cellular response to thymidine induced replication fork stress</article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume>, <fpage>2937</fpage>–<lpage>2945</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddh316</pub-id>)<pub-id pub-id-type="pmid">15459181</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krakoff</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Reichard</surname><given-names>P</given-names></name></person-group>
<year>1968</year>
<article-title>Inhibition of ribonucleoside diphosphate reductase by hydroxyurea</article-title>. <source/>Cancer Res.
<volume>28</volume>, <fpage>1559</fpage>–<lpage>1565</lpage>.<pub-id pub-id-type="pmid">4876978</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hakansson</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hofer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thelander</surname><given-names>L</given-names></name></person-group>
<year>2006</year>
<article-title>Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>7834</fpage>–<lpage>7841</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M512894200</pub-id>)<pub-id pub-id-type="pmid">16436374</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Kuchta</surname><given-names>RD</given-names></name></person-group>
<year>1993</year>
<article-title>DNA polymerase epsilon: aphidicolin inhibition and the relationship between polymerase and exonuclease activity</article-title>. <source/>Biochemistry
<volume>32</volume>, <fpage>8568</fpage>–<lpage>8574</lpage>. (<pub-id pub-id-type="doi">10.1021/bi00084a025</pub-id>)<pub-id pub-id-type="pmid">8395209</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vesela</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chroma</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Turi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mistrik</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Common chemical inductors of replication stress: focus on cell-based studies</article-title>. <source/>Biomolecules
<volume>7</volume>, <fpage>E19</fpage> (<pub-id pub-id-type="doi">10.3390/biom7010019</pub-id>)<pub-id pub-id-type="pmid">28230817</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohanty</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Town</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yagi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Scheidig</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Allore</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>AC</given-names></name></person-group>
<year>2008</year>
<article-title>Defective p53 engagement after the induction of DNA damage in cells deficient in topoisomerase 3β</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>105</volume>, <fpage>5063</fpage>–<lpage>5068</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0801235105</pub-id>)<pub-id pub-id-type="pmid">18367668</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Replication stress induces micronuclei comprising of aggregated DNA double-strand breaks</article-title>. <source/>PLoS ONE
<volume>6</volume>, <fpage>e18618</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0018618</pub-id>)<pub-id pub-id-type="pmid">21525980</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahba</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gore</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Koshland</surname><given-names>D</given-names></name></person-group>
<year>2013</year>
<article-title>The homologous recombination machinery modulates the formation of RNA-DNA hybrids and associated chromosome instability</article-title>. <source/>eLife
<volume>2</volume>, <fpage>e00505</fpage> (<pub-id pub-id-type="doi">10.7554/eLife.00505</pub-id>)<pub-id pub-id-type="pmid">23795288</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohle</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tesorero</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schermann</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dobrev</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sinning</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>T</given-names></name></person-group>
<year>2016</year>
<article-title>Transient RNA-DNA hybrids are required for efficient double-strand break repair</article-title>. <source/>Cell
<volume>167</volume>, <fpage>1001</fpage>–<lpage>1013</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.001</pub-id>)<pub-id pub-id-type="pmid">27881299</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yasuhara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hagiwara</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shiotani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yamauchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakada</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Miyagawa</surname><given-names>K</given-names></name></person-group>
<year>2018</year>
<article-title>Human Rad52 promotes XPG-mediated R-loop processing to initiate transcription-associated homologous recombination repair</article-title>. <source/>Cell
<volume>175</volume>, <fpage>558</fpage>–<lpage>570</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2018.08.056</pub-id>)<pub-id pub-id-type="pmid">30245011</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguilera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gomez-Gonzalez</surname><given-names>B</given-names></name></person-group>
<year>2017</year>
<article-title>DNA-RNA hybrids: the risks of DNA breakage during transcription</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>24</volume>, <fpage>439</fpage>–<lpage>443</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb.3395</pub-id>)<pub-id pub-id-type="pmid">28471430</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorthi</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma</article-title>. <source/>Nature
<volume>555</volume>, <fpage>387</fpage>–<lpage>391</lpage>. (<pub-id pub-id-type="doi">10.1038/nature25748</pub-id>)<pub-id pub-id-type="pmid">29513652</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>AJ</given-names></name></person-group>
<year>2016</year>
<article-title>Unsolved mystery: the role of BRCA1 in DNA end-joining</article-title>. <source/>J. Radiat. Res.
<volume>57</volume>(<issue>Suppl. 1</issue>), <fpage>i18</fpage>–<lpage>i24</lpage>. (<pub-id pub-id-type="doi">10.1093/jrr/rrw032</pub-id>)<pub-id pub-id-type="pmid">27170701</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Mi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gou</surname><given-names>X</given-names></name></person-group>
<year>2018</year>
<article-title>Glioma in schizophrenia: is the risk higher or lower?</article-title>
<source/>Front. Cell. Neurosci.
<volume>12</volume>, <fpage>289</fpage> (<pub-id pub-id-type="doi">10.3389/fncel.2018.00289</pub-id>)<pub-id pub-id-type="pmid">30233327</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markkanen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Dianov</surname><given-names>GL</given-names></name></person-group>
<year>2016</year>
<article-title>DNA damage and repair in schizophrenia and autism: implications for cancer comorbidity and beyond</article-title>. <source/>Int. J. Mol. Sci.
<volume>17</volume>, <fpage>E856</fpage> (<pub-id pub-id-type="doi">10.3390/ijms17060856</pub-id>)<pub-id pub-id-type="pmid">27258260</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katsel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fam</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Purohit</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Haroutunian</surname><given-names>V</given-names></name></person-group>
<year>2013</year>
<article-title>Cell cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected]</article-title>. <source/>PLoS ONE
<volume>8</volume>, <fpage>e68361</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0068361</pub-id>)<pub-id pub-id-type="pmid">23861893</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Catts</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Catts</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Jablensky</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chandler</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weickert</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Lavin</surname><given-names>MF</given-names></name></person-group>
<year>2012</year>
<article-title>Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia</article-title>. <source/>World J. Biol. Psychiatry
<volume>13</volume>, <fpage>114</fpage>–<lpage>125</lpage>. (<pub-id pub-id-type="doi">10.3109/15622975.2011.565073</pub-id>)<pub-id pub-id-type="pmid">21830993</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwab</surname><given-names>RA</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>The Fanconi anemia pathway maintains genome stability by coordinating replication and transcription</article-title>. <source/>Mol. Cell
<volume>60</volume>, <fpage>351</fpage>–<lpage>361</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.012</pub-id>)<pub-id pub-id-type="pmid">26593718</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Maksimovic</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oshlack</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Earnshaw</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Kalitsis</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hudson</surname><given-names>DF</given-names></name></person-group>
<year>2013</year>
<article-title>Condensin I associates with structural and gene regulatory regions in vertebrate chromosomes</article-title>. <source/>Nat. Commun.
<volume>4</volume>, <fpage>2537</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms3537</pub-id>)<pub-id pub-id-type="pmid">24088984</pub-id></mixed-citation>
</ref>
<ref id="RSOB190222C73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crowley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Waterhouse</surname><given-names>NJ</given-names></name></person-group>
<year>2016</year>
<article-title>Measuring survival of adherent cells with the colony-forming assay</article-title>. <source/>Cold Spring Harb. Protoc.
<volume>2016</volume>, <fpage>721</fpage>–<lpage>724</lpage>. (<pub-id pub-id-type="doi">10.1101/pdb.prot087171</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB190222C74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ran</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Agarwala</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name></person-group>
<year>2013</year>
<article-title>Genome engineering using the CRISPR–Cas9 system</article-title>. <source/>Nat. Protoc.
<volume>8</volume>, <fpage>2281</fpage>–<lpage>2308</lpage>. (<pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id>)<pub-id pub-id-type="pmid">24157548</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>